Ascopharm GmbH has been acquired by Adiuva Capital GmbH
Adiuva Capital has acquired Ascopharm GmbH and Revomed GmbH from the company founder Karl-Heinz Oppermann in a management buyout transaction.
Founded in 1977, Ascopharm provides high quality nutritional supplements, OTC drugs, minerals, vitamins, and cosmetics. From its headquarters in Wernigerode, Germany, the company supplies over 200,000 regular customers. The products are sold under the Ascopharm and Sovita brands to consumers. B2B customers are served through the Revomed brand.
Adiuva Capital is a long-term oriented, entrepreneurial investment company. With headquarters in Hamburg, Adiuva is owner-managed and provides equity for medium-sized European enterprises, with a particular focus on the German-speaking region.
Adiuva Capital acquired Ascopharm as part of a succession arrangement from the company founder Karl-Heinz Oppermann and will support Ascopharm in expanding their product portfolio, developing the B2B part of the business, and strengthening the online activities. Hannelore Hütcher becomes Managing Partner of Ascopharm.
Oaklins' team in Germany acted as the exclusive financial advisors to the seller and structured the entire M&A process.
Talk to the deal team
Related deals
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn moreMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Learn moreQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Learn more